PGI2 CHRONIC HEPATITIS C VIRUS (HCV) TREATMENT COSTS IN THE TERTIARY REFERENCE HOSPITAL DAS CLÍNICAS—UNIVERSITY OF SÃO PAULO SCHOOL OF MEDICINE (HC-FMUSP) - Value in Healthdoi:10.1016/S1098-3015(10)75406-1Nabeshima, MAFerreira, R
Hepatitis C virus (HCV) infection remains a significant medical concern in the United States and around the world. It is still one of the leading causes of chronic liver disease, and, for more than 20 years, there has been little progress in the treatment of HCV infection. The advent of ...
Prices, Costs, and Affordability of New Medicines for Hepatitis C in 30 Countries: An Economic Analysis New hepatitis C virus (HCV) medicines have markedly improved treatment efficacy and regimen tolerability. However, their high prices have limited access, p... S Iyengar,K Tay-Teo,S Vogler,....
摘要: Background Limited data is available on Hepatitis C disease prevalence, treatment initiation and its cost-effectiveness in Lebanon and the whole Middle East. ObjectiveThe aim of the study is to...关键词...
Medicare increases hepatitis C testing, despite high treatment costs12Next A decision has been made by the Centers for Medicare and Medicaid Services (CMS) for Medicare to cover hepatitis C virus (HCV) testing for adults. Testing will include a single screeni...
hepatitis C virus -- sofosbuvir plus simeprevir for 12 weeks -- is extremely well tolerated and is probably going to be more than 90% successful. But it costs about $1800 a day. So we are in this uncomfortable position where we have this extraordinary advance in treatment, both in ...
In Japan, 1.5–2 million people are chronically infected with hepatitis C virus (HCV) infection. New direct-acting antiviral agents (DAA) offer an unprecedented opportunity to cure HCV. While the price of HCV treatment decreased recently in most countrie
Cost-effectiveness of chronic hepatitis C treatment in Spain In this study we evaluated the pharmacologic costs of treatment, considering recommendations on both the duration of therapy and sustained virological resp... HA Saflo,JMH Guijo - 《Gastroenterologia Y Hepatologia》 被引量: 67发表: 2009...
Direct-acting antivirals are effective for chronic hepatitis C treatment in elderly patients: a real-world study of 17487 patients The mean age of patients with chronic hepatitis C virus (HCV) infection in the USA has been increasing. Despite the increasing proportion of HCV-infected e......
A study led by Boston Medical Center (BMC) researchers demonstrates that while new therapies to treat Hepatitis C Virus (HCV) are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients. The findings of the study, led by Benjamin P....